Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsConstruction in ProgressCurrent AssetsCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Intangibles (2017 - 2025)

Dr Reddys Laboratories has reported Intangibles over the past 9 years, most recently at $7.6 million for Q1 2025.

  • For Q1 2025, Intangibles fell 98.28% year-over-year to $7.6 million; the TTM value through Mar 2025 reached $7.6 million, down 98.28%, while the annual FY2025 figure was $1.1 billion, 155.98% up from the prior year.
  • Intangibles for Q1 2025 was $7.6 million at Dr Reddys Laboratories, down from $444.9 million in the prior quarter.
  • Over five years, Intangibles peaked at $488.9 million in Q1 2021 and troughed at $7.6 million in Q1 2025.
  • A 5-year average of $335.8 million and a median of $375.3 million in 2023 define the central range for Intangibles.
  • Biggest five-year swings in Intangibles: increased 28.06% in 2021 and later plummeted 98.28% in 2025.
  • Year by year, Intangibles stood at $488.9 million in 2021, then dropped by 25.89% to $362.3 million in 2022, then increased by 3.57% to $375.3 million in 2023, then grew by 18.57% to $444.9 million in 2024, then plummeted by 98.28% to $7.6 million in 2025.
  • Business Quant data shows Intangibles for RDY at $7.6 million in Q1 2025, $444.9 million in Q1 2024, and $375.3 million in Q1 2023.